Background Colorectal cancer is a common and often fatal malignancy. Currently, the
modifications that alter disease outcome include early symptom recognition, population …

Colorectal cancer (CRC) is among the most common human malignancies and remains a
leading cause of cancer-related morbidity and mortality. Colorectal carcinogenesis is a …

Colorectal cancer (CRC) is the leading cause of cancer-related mortality in western
countries. Adjuvant treatment does not seem to be highly effective and recurrent or …

[Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma]. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …

Colorectal cancer is one of the commonest malignancies worldwide. Recently, there has
been much speculation regarding the role of cyclooxygenase-2 (COX-2) suppression in …

Chemoprevention began to be considered as a potential strategy for lowering the incidence
of cancer and cancer‐related deaths in the 1970s. For clinical chemoprevention trials …

Background: Colorectal cancer (CRC) is one of the most common cancers worldwide and a
prevalent cause of morbidity and mortality. CRC has a natural history of transition from a …

Chemoprevention means the use of agents to prevent, delay, or reverse carcinogenesis.
This review was designed to critically discuss the most promising agents in colorectal cancer …

Colorectal cancer (CRC) is the second most common fatal malignancy in the Western world,
with more than 150,000 new cases accounting for 55,000 deaths in the United States every …

INTRODUCTION: Colorectal chemoprevention is a strategy aimed at preventing tumour
progression before irreversible changes to the proteome are in full progress …